Atea Pharmaceuticals Inc
About
Atea Pharmaceuticals Inc (NASDAQ:AVIR) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 5 2026
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 26 2026
Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call on March 5, 2026
Feb 24 2026
Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
Jan 8 2026
Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
Jan 6 2026
Atea Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Financials
Revenue
$192.18 M
Market Cap
$467.68 M
EPS
-1.94